BIOTRONIK Home Monitoring® – Continuity of Care
Remote patient management with Home Monitoring offers the opportunity to deliver intelligent, event-driven care. This care is designed to improve clinical outcomes without added patient inconvenience. BIOTRONIK Home Monitoring® allows follow-up appointments to be catered to each patient, so they are seen when needed, rather than on a pre-set schedule. This helps assure that patients are monitored and healthcare providers are notified of clinically relevant device events in between in-person visits.
Studies show that Home Monitoring:
- Provides early detection to enable early interventions—improving outcomes1,5 and reducing workload6
- Improves patient clinical status and reduces mortality5,7
- Can safely and efficiently reduce and replace face-to-face follow ups,1,2,3,4 easing staff workloads4
- Helps provide optimal patient satisfaction
BIOTRONIK Home Monitoring® – Continuity of Care
- Remote patient management with Home Monitoring offers the opportunity to deliver intelligent, event-driven care. This care is designed to improve clinical outcomes without added patient inconvenience. BIOTRONIK Home Monitoring® allows follow-up appointments to be catered to each patient, so they are seen when needed, rather than on a pre-set schedule. This helps assure that patients are monitored and healthcare providers are notified of clinically relevant device events in between in-person visits.
Studies show that Home Monitoring:
- Provides early detection to enable early interventions—improving outcomes1,5 and reducing workload6
- Improves patient clinical status and reduces mortality5,7
- Can safely and efficiently reduce and replace face-to-face follow ups,1,2,3,4 easing staff workloads4
- Helps provide optimal patient satisfaction8
How BIOTRONIK Home Monitoring® Works:
How BIOTRONIK Home Monitoring® Works:
Unique Advantages of BIOTRONIK Home Monitoring®
- Automatic daily wireless data transmission and verification from day one across all devices
- On-demand, web-based access to complete event reports, including high definition IEGMs
- Alert-based patient care with an intelligent traffic light system for easy triage
- Remote controlled alert settings via the web-based Home Monitoring Service Center
- QuickCheck function. This allows for current patient data to be triggered within 3-4 min., including a full IEGM
- Mobile transmitter with worldwide cellular connectivity at no charge to the patient
- Easy-to-use “plug and play” patient transmitter with no patient interaction needed to complete data transmissions
- Flexible data sharing and EHR compatible
Unique Advantages of BIOTRONIK Home Monitoring®
- Automatic daily wireless data transmission and verification from day one across all devices
- On-demand, web-based access to complete event reports, including high definition IEGMs
- Alert-based patient care with an intelligent traffic light system for easy triage
- Remote controlled alert settings via the web-based Home Monitoring Service Center
- QuickCheck function. This allows for current patient data to be triggered within 3-4 min., including a full IEGM
- Mobile transmitter with worldwide cellular connectivity at no charge to the patient
- Easy-to-use “plug and play” patient transmitter with no patient interaction needed to complete data transmissions
- Flexible data sharing and EHR compatible
TRUST STUDY
ECOST STUDY
RM-ALONE STUDY
HOMASQ STUDY
RM-ALONE STUDY
TRUST STUDY
ECOST STUDY
RM-ALONE STUDY
HOMASQ STUDY
RM-ALONE STUDY
1 TRUST Study. Varma et al., Circulation (2010), 122: 325.
2 REFORM Study. Hindricks et al. European Heart Journal (2014), 98–105
3 COMPAS Study. Mabo et al., European Heart Journal (2012), 33: 1105.
4 RM-ALONE Study. García-Fernández FJ, et al. Eur Heart J. 2019 40(23):1837-1846
5 IN-TIME Study. Hindricks et al., The Lancet (2014), 384: 583-590.
6 ECOST Study. Guedon-Moreau et al., European Heart Journal (2013), 34: 605-614.
7 TRUECOIN Study. Hindricks et al., European Heart Journal 2017, 1749–1755
8 Ricci et al., Europace (2010), 12: 676.
1 TRUST Study. Varma et al., Circulation (2010), 122: 325.
2 REFORM Study. Hindricks et al. European Heart Journal (2014), 98–105
3 COMPAS Study. Mabo et al., European Heart Journal (2012), 33: 1105.
4 RM-ALONE Study. García-Fernández FJ, et al. Eur Heart J. 2019 40(23):1837-1846
5 IN-TIME Study. Hindricks et al., The Lancet (2014), 384: 583-590.
6 ECOST Study. Guedon-Moreau et al., European Heart Journal (2013), 34: 605-614.
7 TRUECOIN Study. Hindricks et al., European Heart Journal 2017, 1749–1755
8 Ricci et al., Europace (2010), 12: 676.